What This Page Is About

This article explores why many Nigerian women struggle with weight in ways that feel disproportionate to their habits, particularly when conditions like PCOS, fibroids, or insulin resistance are involved. It explains how these conditions affect metabolism, appetite, and fat storage, and why GLP-1 medications can change the experience of weight loss.

One-Minute Summary

For many women, weight gain is not driven primarily by food choices or motivation, but by hormonal and metabolic conditions that make the body store fat more easily and resist fat loss. PCOS, insulin resistance, and related disorders change how hunger, blood sugar, and energy use are regulated. Understanding this can help remove shame from the process and set more realistic expectations for treatment.

When Weight Loss Feels Harder Than It Should

Across Nigeria and the diaspora, many women describe the same pattern. They reduce their portions. They cut out snacks. They attempt fasting. They walk, join gyms, drink slimming teas, and cycle through diets. Yet their weight barely shifts, or returns quickly after any progress.

This experience is deeply frustrating because it feels illogical. The effort does not match the outcome.

For a significant number of women, this disconnect is not behavioural. It is biological.

Conditions such as polycystic ovary syndrome (PCOS), insulin resistance, thyroid disruption, and other hormonal imbalances are common and often under-diagnosed. These conditions alter how the body processes energy, stores fat, and generates hunger signals. As a result, the body can become biased toward weight gain and resistant to weight loss.

This is not a failure of discipline. It is a change in the internal environment.

How Insulin Resistance and Hormones Affect Weight

Insulin is a hormone that regulates how sugar moves from the bloodstream into cells to be used for energy. When the body becomes resistant to insulin, it compensates by producing more of it. Higher circulating insulin makes fat storage easier and fat breakdown more difficult. It also increases hunger and cravings, particularly for carbohydrates.

PCOS and related endocrine disorders often involve some degree of insulin resistance. They also disrupt reproductive hormones, which influence where fat is stored, how appetite is regulated, and how the body responds to calorie restriction.

Many women with these conditions experience:

These features are not cosmetic. They reflect systemic metabolic disruption.

Why Traditional Dieting Often Fails in This Context

Most dieting advice assumes a relatively stable metabolic system. It relies on the idea that reducing calories will reliably reduce weight.

In hormonally disrupted states, this relationship becomes unstable. Calorie restriction can lead to exaggerated hunger, metabolic slowing, and increased stress hormone release. The body becomes more efficient at conserving energy, and fat loss becomes increasingly difficult.

This is why many women report that the stricter they diet, the less their body responds.

The body is not being stubborn. It is defending a new internal balance.

How GLP-1 Medicines Change the Experience

GLP-1 medications work on the gut-brain hormonal network that regulates appetite, satiety, and insulin response. They do not simply suppress hunger. They reshape the signals that drive eating behaviour and metabolic regulation.

In people with insulin resistance or PCOS, this often results in:

For many women, this is the first time their appetite feels proportional to their needs.

This does not mean weight loss becomes effortless. It means the body's signals become easier to work with rather than against.

What This Does and Does Not Mean

It means:

It does not mean:

Treatment is still a process of adjustment, learning, and patience.

When to Seek Medical Care

Seek medical advice if you experience:

These require medical assessment.

Medical Notice

This information is educational and does not replace medical advice. Always seek care from a qualified medical professional for concerning symptoms.